Supreme Court temporarily blocks Purdue Pharma bankruptcy deal shielding Sacklers from opioid lawsuits

The Supreme Court is reviewing a settlement that would shield the Sackler family from civil lawsuits related to the opioid crisis.
The proposed settlement allows Purdue Pharma to emerge from bankruptcy and contribute up to $6 billion to fight the opioid epidemic.
The Biden administration and other critics argue the Sacklers should not be released from legal liability through bankruptcy law.
The Supreme Court will hear arguments in December on whether the settlement's liability releases are valid.
A ruling is expected in early 2023 on the high-profile case involving OxyContin maker Purdue Pharma and the opioid epidemic.